Effects of l-DOPA on striatal iodine-123-FP-CIT binding and behavioral parameters in the rat
Explore this paper's citation graph
Summary
Results indicate a biphasic response with a higher effect on DAT after the lower dose of L-DOPA, and there is preliminary evidence of an association between striatal DAT and motor and exploratory parameters.
- Type
- article
- Published
- 2013-08-01
- Cited by
- 17
- References
- 54
- Access
- Open access
- OpenAlex
- https://openalex.org/W23982164
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:18634820
Keywords
Political science
References
- L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatment.
- In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
- Levodopa and the progression of Parkinson's disease.
- Quantitative analysis of dopamine D2 receptor kinetics with small animal positron emission tomography.
- Role of High‐Affinity Dopamine Uptake and Impulse Activity in the Appearance of Extracellular Dopamine in Striatum After Administration of Exogenous L‐DOPA
- Chronic intermittent L‐DOPA treatment induces changes in dopamine release
- Dopamine Transporter Gene Polymorphism, SPECT Imaging, and Levodopa Response in Patients with Parkinson Disease
- Intranasally applied L-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions.
- Reproducibility and Effect of Levodopa on Dopamine Transporter Function Measurements: A [18F]CFT PET Study
- L-dopa induces Ca(2+)-dependent and tetrodotoxin-sensitive release of endogenous glutamate from rat striatal slices.
- Neurobiology of L-DOPAergic systems.
- Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats
- Nuclear Medicine Communications
- Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients
- Levodopa and pramipexole effects on presynaptic dopamine PET markers and estimated dopamine release
- Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism.
- SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates
- Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys
- Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.
- L-Dopa-Induced Release of Cerebral Monoamines
Cited by
- Deep Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex in Alcohol Use Disorder Patients: Effects on Dopamine Transporter Availability and Alcohol Intake.
- Reduced Dopamine Transporter Availability and Neurocognitive Deficits in Male Patients with Alcohol Dependence
- Relationship between L-DOPA-induced reduction in motor and exploratory activity and degree of DAT binding in the rat
- Quantification of rat brain SPECT with 123I-ioflupane: evaluation of different reconstruction methods and image degradation compensations using Monte Carlo simulation
- PET imaging of dopamine transporters with [(18)F]FE-PE2I: Effects of anti-Parkinsonian drugs.
- Pharmacological treatment with L-DOPA may reduce striatal dopamine transporter binding in in vivo imaging studies
- Relationship Between L-DOPA-Induced Reduction in Motor and Exploratory Activity and Striatal Dopamine D2 Receptor Binding in the Rat
- Intranasal Dopamine Reduces In Vivo [123I]FP-CIT Binding to Striatal Dopamine Transporter: Correlation with Behavioral Changes and Evidence for Pavlovian Conditioned Dopamine Response
- GABAergic control of neostriatal dopamine D2 receptor binding and behaviors in the rat
- Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness.
- GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
- Amantadine enhances nigrostriatal and mesolimbic dopamine function in the rat brain in relation to motor and exploratory activity
- Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control
- FMR1 deletion in rats induces hyperactivity with no changes in striatal dopamine transporter availability
- A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice
- Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats
- The 5-HT1A receptor agonist 8-OH-DPAT modulates motor/exploratory activity, recognition memory and dopamine transporter binding in the dorsal and ventral striatum.
Related papers
No related papers recorded.